Key Highlights

  • Chicago Atlantic Real Estate Finance issued 4,306,754 shares at $14.53 per share as part of a financing arrangement tied to $62.5 million in second-lien notes.
  • The transaction grants an investor group a 16.8% stake in the company’s outstanding common stock, with shares subject to lock-up terms.
  • The notes carry a 12% annual interest rate, with 10% paid in cash and 2% accrued, and feature a weighted average maturity of approximately 12 years.
  • Lock-up terms restrict share sales for three to six months, with 20% released after three months and the remaining 80% after six.

Deal Terms Unveiled

Chicago Atlantic Real Estate Finance (NASDAQ: REFI) completed a financing transaction on July 9, 2026, issuing 4,306,754 shares of its common stock in exchange for $62.5 million in second-lien promissory notes. The shares were priced at $14.53 each, reflecting a structured capital raise with an institutional investor. The transaction bolsters REFI’s financial position while expanding its portfolio of cannabis-related real estate assets, a sector known for its specialized financing needs and regulatory complexities.

Note Structure and Security

The $62.5 million in second-lien notes carry an annual interest rate of 12%, with 10% paid in cash and 2% accrued as payment-in-kind. These notes are secured by mortgages on a portfolio of retail properties leased to cannabis operators, though they remain subordinate to existing senior debt totaling approximately $39 million.

Stock Lock-Up Restrictions

The shares issued to the investor group, representing approximately 16.8% of REFI’s outstanding common stock, are subject to lock-up agreements designed to stabilize the company’s stock price post-transaction. Under the terms, 20% of the shares may not be sold or transferred for three months following the closing, while the remaining 80% are restricted for six months. Limited exceptions apply, but the restrictions aim to mitigate potential market volatility during the early stages of the investment.

Merger Implications

The financing aligns with REFI’s pending merger with Chicago Atlantic BDC, a deal announced on June 17, 2026. The additional shares issued in this transaction will adjust the exchange ratio for the merger, though the completion of the deal remains contingent on regulatory and shareholder approvals. REFI has stated that the financing complies with the terms of the merger agreement, ensuring no disruptions to the planned consolidation.

The merger is expected to create a larger, more diversified platform for financing cannabis-related real estate, a sector that has seen increased institutional interest despite regulatory uncertainties.

Regulatory and Disclosure Details

The shares issued in the transaction were exempt from registration under the Securities Act of 1933, as the offering qualified under Rule 506 of Regulation D. Participation was limited to accredited investors, and the notes were not offered to the general public. REFI filed the relevant transaction documents with the SEC, including the loan agreement and lock-up letter, which were made available as exhibits to its public filings.

Investor Considerations

The 12% interest rate on the second-lien notes reflects the elevated risk profile associated with cannabis-related real estate financing. Investors should closely monitor the progress of the merger, as well as the release of locked-up shares, as these factors could influence REFI’s stock performance and liquidity in the near term.

Forward-Looking Statements

REFI’s public filings include forward-looking statements regarding the expected completion of the merger and the performance of the newly issued notes. Key risks include market volatility, shifts in cannabis regulations, and potential tenant defaults, all of which could impact the company’s financial results. REFI has cautioned that actual outcomes may differ from projections, and investors are encouraged to review the company’s SEC filings for a comprehensive overview of the risks and uncertainties involved.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.